LATTICE SEMICONDUCTOR CORP

**SIGNAL NOTE: LSCC Position Initiation by Eventide AM** Note: Lattice Semiconductor (LSCC) is a semiconductor company, not a biotech/pharma company, so this signal falls outside typical drug development catalysts. However, Eventide's values-based investment thesis may reflect LSCC's positioning in edge computing and data center applications where biotech/medtech applications (diagnostics, wearables, imaging) increasingly rely on low-power FPGA solutions. The $45.7M position (621k shares) suggests conviction in secular tailwinds rather than near-term clinical catalysts.